Skip to content

HEW PHARMA

Active Private limited companyfounded 2017active for 9 yearsHeiken 5, 2920 KalmthoutKBO/BCE: BE 0681.590.393 subsidiary of

Board

3 directors, no change since 2022
Manager (not named in the articles)
since 19-09-2017 term without a fixed end
listed in the 2025 annual accounts, filed on 30-09-2026
Manager (not named in the articles), permanent representative
since 19-09-2017 term without a fixed end
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 30-09-2026
Director
since 14-02-2022 term without a fixed end
listed in the 2025 annual accounts, filed on 30-09-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Iedere zaakvoerder afzonderlijk, ook wanneer er meerdere zijn, vertegenwoordigt de vennootschap jegens derden en in rechte als eiser of als verweerder.”
deed of 22-09-2017
Permanent representatives 1
Permanent representative, for
appointed by deed of 22-09-2017

Office holders in the KBO →

Mandates through the years

3 names, the dashed line is today

Manager (not named in the articles)

Manager (not named in the articles)

Director
Boardmandate already running before its first mention
Mandates as a list
    • Manager (not named in the articles), from 19-09-2017 to date
    • Manager (not named in the articles), from 19-09-2017 to date
    • Director, since before 31-12-2021
With Starter you also see 1 former office holder in the mandate history. See the plans →

Control

Parent
Equity €1.8m
Profit €30,126 in 2025 (profit €38,250 in 2024)
Checked score
60%
This company
HEW PHARMA
Equity €279,177
Profit €30,396 in 2025

and 1 other shareholder

Capital

Capital
€18,550
Shares
100
Contribution per share
€186
Equity per share
€2,792 in 2025
Source
deed of 22-09-2017

Owners through the years

as the annual accounts name them
60%
20%
Owners as a list
    • 2021 to 2025: 20%

Source: parent in its own accounts, lists of holdings in the owners' accounts

Articles of association

Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
deed of 22-09-2017 (in Dutch)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Wednesday of June at 19:00
deed of 19-06-2019 (in Dutch)
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
Vereffenaars leggen plan verdeling activa onder schuldeisers voor akkoord voor aan bevoegde rechtbank van koophandel, tenzij ontbinding met onmiddellijke afslui…
deed of 22-09-2017 (in Dutch)

Shareholders

2 owners

Owners 2

  • parent
    Equity €1.8m Profit of €30,126 in 2025 (profit of €38,250 in 2024) Checked score
    Sourceaccounts 30-06-2025
    60%
  • Equity €573.3m Profit of €50.0m in 2025 (profit of €34.0m in 2024) Checked score
    Sourceaccounts 2025
    20%

Capital transactions

Shareholders according to the deeds
At incorporation deed of 19-06-2019 ↗
  • 60 shares (60%)
  • 20 shares (20%)
  • 20 shares (20%)
At incorporation deed of 22-09-2017 ↗
  • 60 shares (60%) · €11,130
  • 20 shares (20%) · €3,710
  • 20 shares (20%) · €3,710
Capital over time
  1. 19-06-2019 Incorporation · 100 shares
  2. 22-09-2017 Incorporation · €18,550 · 100 shares

Next steps